Impaired CBS-H2S signaling axis contributes to MPTP-induced neurodegeneration in a mouse model of Parkinson’s disease

•Plasma and striatal sulfide levels were decreased in MPTP-induced PD mouse model.•CBS expression was reduced in the striatum and glial cells of MPTP-treated mice.•Striatal CBS overexpression rescued MPTP-induced motor deficits and DA neuron losses.•CBS overexpression reduced the MPTP-induced nitrat...

Full description

Saved in:
Bibliographic Details
Published inBrain, behavior, and immunity Vol. 67; pp. 77 - 90
Main Authors Yuan, Yu-Qing, Wang, Ya-Li, Yuan, Bao-Shi, Yuan, Xin, Hou, Xiao-Ou, Bian, Jin-Song, Liu, Chun-Feng, Hu, Li-Fang
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •Plasma and striatal sulfide levels were decreased in MPTP-induced PD mouse model.•CBS expression was reduced in the striatum and glial cells of MPTP-treated mice.•Striatal CBS overexpression rescued MPTP-induced motor deficits and DA neuron losses.•CBS overexpression reduced the MPTP-induced nitrative stress and α-syn nitration.•Glia CBS overexpression offered both direct and indirect protection to DA neurons. Hydrogen sulfide (H2S), a novel neuromodulator, is linked to the pathogenesis of several neurodegenerative disorders. Exogenous application of H2S exerts neuroprotection via anti-inflammation and anti-oxidative stress in animal and cellular models of Parkinson’s disease (PD). However, the role of endogenous H2S and the contribution of its various synthases in PD remain unclear. In the present study, we found a decline of plasma and striatal sulfide level in 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced PD mouse model. Interestingly, among the three H2S generating enzymes, only cystathionine β-synthase (CBS) expression was largely reduced in the striatum of MPTP-treated mice. The in vitro study confirmed a significant decrease of CBS expression in 1-methyl-4-phenylpyridinium (MPP+)-stimulated astrocytes and microglia, but not in neurons or SH-SY5Y dopaminergic cells. Striatal CBS overexpression, elicited by stereotaxic delivery with Cbs gene using recombinant adeno-associated-virus (rAAV-Cbs), successfully enhanced the sulfide level in the striatum and partially rescued the MPTP-induced dopaminergic neurotoxicity in the midbrain. Specifically, striatal CBS overexpression alleviated the motor deficits and dopaminergic neuron losses in the nigro-striatal pathway, with a concomitant inhibition of glial activation in MPTP-treated mice. Furthermore, compared to rAAV-Vector, rAAV-Cbs injection reduced the aberrant accumulation of nitric oxide and 3-nitrotyrosine (an indicator of protein nitration) in the striatum of MPTP-treated mice. Notably, it also attenuated the increase of nitrated α-synuclein level in MPTP mice. The in vitro study demonstrated that lentivirus-mediated CBS overexpression elevated the sulfide generation in glial cells. Moreover, glial CBS overexpression offered protection to midbrain dopaminergic neurons through repressing nitric oxide overproduction in both glial and neuronal cells induced by MPP+. Taken together, our data suggest that impaired CBS-H2S axis may contribute to the pathogenesis of PD, and that modulation of this axis may become a novel therapeutic approach for PD.
AbstractList Hydrogen sulfide (H2S), a novel neuromodulator, is linked to the pathogenesis of several neurodegenerative disorders. Exogenous application of H2S exerts neuroprotection via anti-inflammation and anti-oxidative stress in animal and cellular models of Parkinson's disease (PD). However, the role of endogenous H2S and the contribution of its various synthases in PD remain unclear. In the present study, we found a decline of plasma and striatal sulfide level in 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced PD mouse model. Interestingly, among the three H2S generating enzymes, only cystathionine β-synthase (CBS) expression was largely reduced in the striatum of MPTP-treated mice. The in vitro study confirmed a significant decrease of CBS expression in 1-methyl-4-phenylpyridinium (MPP+)-stimulated astrocytes and microglia, but not in neurons or SH-SY5Y dopaminergic cells. Striatal CBS overexpression, elicited by stereotaxic delivery with Cbs gene using recombinant adeno-associated-virus (rAAV-Cbs), successfully enhanced the sulfide level in the striatum and partially rescued the MPTP-induced dopaminergic neurotoxicity in the midbrain. Specifically, striatal CBS overexpression alleviated the motor deficits and dopaminergic neuron losses in the nigro-striatal pathway, with a concomitant inhibition of glial activation in MPTP-treated mice. Furthermore, compared to rAAV-Vector, rAAV-Cbs injection reduced the aberrant accumulation of nitric oxide and 3-nitrotyrosine (an indicator of protein nitration) in the striatum of MPTP-treated mice. Notably, it also attenuated the increase of nitrated α-synuclein level in MPTP mice. The in vitro study demonstrated that lentivirus-mediated CBS overexpression elevated the sulfide generation in glial cells. Moreover, glial CBS overexpression offered protection to midbrain dopaminergic neurons through repressing nitric oxide overproduction in both glial and neuronal cells induced by MPP+. Taken together, our data suggest that impaired CBS-H2S axis may contribute to the pathogenesis of PD, and that modulation of this axis may become a novel therapeutic approach for PD.Hydrogen sulfide (H2S), a novel neuromodulator, is linked to the pathogenesis of several neurodegenerative disorders. Exogenous application of H2S exerts neuroprotection via anti-inflammation and anti-oxidative stress in animal and cellular models of Parkinson's disease (PD). However, the role of endogenous H2S and the contribution of its various synthases in PD remain unclear. In the present study, we found a decline of plasma and striatal sulfide level in 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced PD mouse model. Interestingly, among the three H2S generating enzymes, only cystathionine β-synthase (CBS) expression was largely reduced in the striatum of MPTP-treated mice. The in vitro study confirmed a significant decrease of CBS expression in 1-methyl-4-phenylpyridinium (MPP+)-stimulated astrocytes and microglia, but not in neurons or SH-SY5Y dopaminergic cells. Striatal CBS overexpression, elicited by stereotaxic delivery with Cbs gene using recombinant adeno-associated-virus (rAAV-Cbs), successfully enhanced the sulfide level in the striatum and partially rescued the MPTP-induced dopaminergic neurotoxicity in the midbrain. Specifically, striatal CBS overexpression alleviated the motor deficits and dopaminergic neuron losses in the nigro-striatal pathway, with a concomitant inhibition of glial activation in MPTP-treated mice. Furthermore, compared to rAAV-Vector, rAAV-Cbs injection reduced the aberrant accumulation of nitric oxide and 3-nitrotyrosine (an indicator of protein nitration) in the striatum of MPTP-treated mice. Notably, it also attenuated the increase of nitrated α-synuclein level in MPTP mice. The in vitro study demonstrated that lentivirus-mediated CBS overexpression elevated the sulfide generation in glial cells. Moreover, glial CBS overexpression offered protection to midbrain dopaminergic neurons through repressing nitric oxide overproduction in both glial and neuronal cells induced by MPP+. Taken together, our data suggest that impaired CBS-H2S axis may contribute to the pathogenesis of PD, and that modulation of this axis may become a novel therapeutic approach for PD.
•Plasma and striatal sulfide levels were decreased in MPTP-induced PD mouse model.•CBS expression was reduced in the striatum and glial cells of MPTP-treated mice.•Striatal CBS overexpression rescued MPTP-induced motor deficits and DA neuron losses.•CBS overexpression reduced the MPTP-induced nitrative stress and α-syn nitration.•Glia CBS overexpression offered both direct and indirect protection to DA neurons. Hydrogen sulfide (H2S), a novel neuromodulator, is linked to the pathogenesis of several neurodegenerative disorders. Exogenous application of H2S exerts neuroprotection via anti-inflammation and anti-oxidative stress in animal and cellular models of Parkinson’s disease (PD). However, the role of endogenous H2S and the contribution of its various synthases in PD remain unclear. In the present study, we found a decline of plasma and striatal sulfide level in 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced PD mouse model. Interestingly, among the three H2S generating enzymes, only cystathionine β-synthase (CBS) expression was largely reduced in the striatum of MPTP-treated mice. The in vitro study confirmed a significant decrease of CBS expression in 1-methyl-4-phenylpyridinium (MPP+)-stimulated astrocytes and microglia, but not in neurons or SH-SY5Y dopaminergic cells. Striatal CBS overexpression, elicited by stereotaxic delivery with Cbs gene using recombinant adeno-associated-virus (rAAV-Cbs), successfully enhanced the sulfide level in the striatum and partially rescued the MPTP-induced dopaminergic neurotoxicity in the midbrain. Specifically, striatal CBS overexpression alleviated the motor deficits and dopaminergic neuron losses in the nigro-striatal pathway, with a concomitant inhibition of glial activation in MPTP-treated mice. Furthermore, compared to rAAV-Vector, rAAV-Cbs injection reduced the aberrant accumulation of nitric oxide and 3-nitrotyrosine (an indicator of protein nitration) in the striatum of MPTP-treated mice. Notably, it also attenuated the increase of nitrated α-synuclein level in MPTP mice. The in vitro study demonstrated that lentivirus-mediated CBS overexpression elevated the sulfide generation in glial cells. Moreover, glial CBS overexpression offered protection to midbrain dopaminergic neurons through repressing nitric oxide overproduction in both glial and neuronal cells induced by MPP+. Taken together, our data suggest that impaired CBS-H2S axis may contribute to the pathogenesis of PD, and that modulation of this axis may become a novel therapeutic approach for PD.
Author Yuan, Xin
Bian, Jin-Song
Liu, Chun-Feng
Wang, Ya-Li
Hou, Xiao-Ou
Yuan, Yu-Qing
Yuan, Bao-Shi
Hu, Li-Fang
Author_xml – sequence: 1
  givenname: Yu-Qing
  surname: Yuan
  fullname: Yuan, Yu-Qing
  organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China
– sequence: 2
  givenname: Ya-Li
  surname: Wang
  fullname: Wang, Ya-Li
  organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China
– sequence: 3
  givenname: Bao-Shi
  surname: Yuan
  fullname: Yuan, Bao-Shi
  organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China
– sequence: 4
  givenname: Xin
  surname: Yuan
  fullname: Yuan, Xin
  organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China
– sequence: 5
  givenname: Xiao-Ou
  surname: Hou
  fullname: Hou, Xiao-Ou
  organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China
– sequence: 6
  givenname: Jin-Song
  surname: Bian
  fullname: Bian, Jin-Song
  organization: Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
– sequence: 7
  givenname: Chun-Feng
  surname: Liu
  fullname: Liu, Chun-Feng
  organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China
– sequence: 8
  givenname: Li-Fang
  orcidid: 0000-0001-8326-7779
  surname: Hu
  fullname: Hu, Li-Fang
  email: hulifang@suda.edu.cn
  organization: Institute of Neuroscience, Soochow University, Suzhou 215123, China
BookMark eNqFkcFu1DAQQC1UpG5LP6A3H7kktR2vE4sTrKCtVMRKbc-W40xWs83ai-0AvfEb_B5fgsty6qFcZqTRvNHMmxNy5IMHQs45qznj6mJb9z3WgvG2Zm3Nl_oVWXCmWSV4o4_IgnWdrkqZH5OTlLaMsWXDuwX5fr3bW4ww0NWH2-pK3NKEG28n9Btqf2CiLvgcsZ8zJJoD_by-W1foh9kVxMMcwwAb8BBtxuApemrpLswJShxgomGkaxsf0Kfgf__8leiACWyCN-T1aKcEZ__yKbn_9PFudVXdfLm8Xr2_qZyUKle9FCAaKUfGFOim66RQ1rUwKjWOYJUVw-i0dFrLvhW8tYJDx8Wy5aqRroPmlLw9zN3H8HWGlM0Ok4Npsh7KmoZroVTHtRaltT20uhhSijAah_nvWTlanAxn5km12Zqi2jypNqw1xWkh-TNyH3Fn4-OLzLsDA-X6bwjRJIfgi9byDZfNEPBFWj-jXXkZOjs9wON_2D9qu615
CitedBy_id crossref_primary_10_1016_j_neuro_2024_06_006
crossref_primary_10_1371_journal_pone_0264891
crossref_primary_10_18632_aging_102394
crossref_primary_10_1021_acschemneuro_8b00288
crossref_primary_10_1096_fj_202002696RR
crossref_primary_10_3390_antiox12030652
crossref_primary_10_1042_BSR20221006
crossref_primary_10_18632_aging_103443
crossref_primary_10_1016_j_niox_2020_07_002
crossref_primary_10_1089_ars_2022_0174
crossref_primary_10_1016_j_niox_2019_05_008
crossref_primary_10_1016_j_ejphar_2023_175595
crossref_primary_10_3389_fncel_2019_00366
crossref_primary_10_1016_j_phrs_2024_107507
crossref_primary_10_1038_s41531_024_00798_9
crossref_primary_10_1089_ars_2023_0261
crossref_primary_10_1007_s12640_019_00151_6
crossref_primary_10_1016_j_actbio_2022_11_021
crossref_primary_10_1152_ajpheart_00004_2019
crossref_primary_10_1016_j_neuint_2019_04_011
crossref_primary_10_3390_ijms21103624
crossref_primary_10_1016_j_arr_2021_101262
crossref_primary_10_3390_ijms232012289
crossref_primary_10_3390_biomedicines9020225
crossref_primary_10_3390_biom10070995
crossref_primary_10_1016_j_mehy_2019_109356
crossref_primary_10_1038_s41531_022_00370_3
crossref_primary_10_1080_15384101_2020_1804179
crossref_primary_10_1016_j_ejphar_2023_175966
crossref_primary_10_1186_s12974_024_03268_4
crossref_primary_10_1016_j_neuint_2021_105000
crossref_primary_10_1016_j_neuint_2021_105187
crossref_primary_10_2174_1570159X20666220302101854
crossref_primary_10_1016_j_bbrc_2024_150500
crossref_primary_10_1016_j_phrs_2020_105119
crossref_primary_10_1515_revneuro_2023_0039
crossref_primary_10_1152_ajpendo_00251_2018
crossref_primary_10_12677_IJPN_2022_113006
crossref_primary_10_1016_j_arr_2022_101579
crossref_primary_10_1016_j_tips_2018_03_009
crossref_primary_10_3389_fchem_2017_00072
crossref_primary_10_1039_D5CB00006H
crossref_primary_10_1111_acel_13522
crossref_primary_10_1016_j_mcn_2018_10_002
crossref_primary_10_4103_1673_5374_301026
Cites_doi 10.1089/ars.2010.3517
10.1099/jmm.0.46118-0
10.1371/journal.pgen.1006098
10.1038/70978
10.1046/j.1471-4159.1995.64020936.x
10.1126/scisignal.2000464
10.1016/j.expneurol.2007.05.010
10.1016/j.nbd.2005.08.002
10.1016/j.ymeth.2013.05.020
10.1096/fj.05-3724fje
10.1007/s12264-016-0089-7
10.1089/ars.2011.4507
10.1038/ncomms2623
10.1002/mds.26069
10.1111/j.1471-4159.2004.02937.x
10.1093/cvr/cvq248
10.1007/s12272-016-0802-0
10.1016/j.bbrc.2014.07.107
10.1083/jcb.201003122
10.1155/2013/964034
10.1212/WNL.38.8.1285
10.1007/BF00316435
10.1111/j.1471-4159.2006.04283.x
10.1523/JNEUROSCI.16-03-01066.1996
10.1161/CIRCULATIONAHA.107.753467
10.1016/S0002-9440(10)64781-5
10.1111/j.1474-9726.2009.00543.x
10.1089/ars.2010.3671
ContentType Journal Article
Copyright 2017 Elsevier Inc.
Copyright © 2017 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2017 Elsevier Inc.
– notice: Copyright © 2017 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
7X8
DOI 10.1016/j.bbi.2017.07.159
DatabaseName CrossRef
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1090-2139
EndPage 90
ExternalDocumentID 10_1016_j_bbi_2017_07_159
S0889159117303884
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
23N
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
71M
8P~
9JM
9JO
AAAJQ
AADFP
AAEDT
AAEDW
AAGJA
AAGUQ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABCQJ
ABFNM
ABFRF
ABIVO
ABJNI
ABMAC
ABOYX
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACRLP
ACRPL
ACVFH
ACXNI
ADBBV
ADCNI
ADEZE
ADFGL
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CAG
CJTIS
COF
CS3
DM4
DU5
EBS
EFBJH
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMG
HMQ
HVGLF
HZ~
IHE
J1W
KOM
L7B
LG5
LUGTX
LZ5
M2U
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OH0
OKEIE
OU-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SIN
SNS
SPCBC
SSB
SSN
SSY
SSZ
T5K
TN5
UAP
UNMZH
UPT
WUQ
XPP
XSW
Z5R
ZGI
ZMT
~G-
~S-
AACTN
AADPK
AAIAV
ABYKQ
AFKWA
AFYLN
AJBFU
AJOXV
AMFUW
EFLBG
RIG
SSI
AAYXX
AFCTW
AGRNS
BNPGV
CITATION
SSH
7X8
ID FETCH-LOGICAL-c446t-b42e2344f006e9388426ac7ef66ffea6a2dfc94c994b7217a21e812571634c8e3
IEDL.DBID .~1
ISSN 0889-1591
1090-2139
IngestDate Fri Jul 11 08:39:50 EDT 2025
Thu Apr 24 23:00:53 EDT 2025
Tue Jul 01 04:10:21 EDT 2025
Fri Feb 23 02:27:22 EST 2024
Tue Aug 26 16:32:22 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Hydrogen sulfide
Neuroinflammation
α-Synuclein nitration
Cystathionine β-synthase
Parkinson’s disease
Nitrative stress
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c446t-b42e2344f006e9388426ac7ef66ffea6a2dfc94c994b7217a21e812571634c8e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-8326-7779
PQID 1926681992
PQPubID 23479
PageCount 14
ParticipantIDs proquest_miscellaneous_1926681992
crossref_citationtrail_10_1016_j_bbi_2017_07_159
crossref_primary_10_1016_j_bbi_2017_07_159
elsevier_sciencedirect_doi_10_1016_j_bbi_2017_07_159
elsevier_clinicalkey_doi_10_1016_j_bbi_2017_07_159
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2018
2018-01-00
20180101
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: January 2018
PublicationDecade 2010
PublicationTitle Brain, behavior, and immunity
PublicationYear 2018
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Kim, Lee, Lee, Park, Lee, Lee, Lee, Lee (b0055) 2016; 39
Mustafa, Gadalla, Sen, Kim, Mu, Gazi, Barrow, Yang, Wang, Snyder (b0095) 2009; 2
Yao, Ding, Zhou, Wang, Hu, Sun, Hu (b0135) 2005; 92
Kida, Yamada, Tokuda, Marutani, Kakinohana, Kaneki, Ichinose (b0050) 2011; 15
Hu, Lu, Tiong, Dawe, Hu, Bian (b0040) 2010; 9
McGeer, Itagaki, Boyes, McGeer (b0090) 1988; 38
Du, Jin, Hong, Li, Wang, Xu, Wang, Zhang, Jia, Liu, Hu (b0015) 2014; 451
Li, Wang, Wang, Hu, Liu (b0065) 2017; 33
Hu, Lu, Hon Wong, Bian (b0045) 2011; 15
Gerhard, Pavese, Hotton, Turkheimer, Es, Hammers, Eggert, Oertel, Banati, Brooks (b0030) 2006; 21
Washio, Sato, Koseki, Takahashi (b0125) 2005; 54
Schulz, Matthews, Muqit, Browne, Beal (b0105) 1995; 64
Siow, Chen, Wan, Chow, Chang (b0110) 2013; 2013
Vandiver, Paul, Xu, Karuppagounder, Rao, Snowman, Ko, Lee, Dawson, Dawson, Sen, Snyder (b0115) 2013; 4
Kleinknecht, Popova, Lazaro, Pinho, Valerius, Outeiro, Braus (b0060) 2016; 12
Lu, Zhao, Tang, Su, Fan, Ding, Bian, Hu (b0085) 2012; 17
Yong, Hu, Wang, Huang, Bian (b0140) 2010; 88
Winslow, Chen, Corrochano, Acevedo-Arozena, Gordon, Peden, Lichtenberg, Menzies, Ravikumar, Imarisio, Brown, O'Kane, Rubinsztein (b0130) 2010; 190
Liberatore, Jackson-Lewis, Vukosavic, Mandir, Vila, McAuliffe, Dawson, Dawson, Przedborski (b0075) 1999; 5
Anderson, Noorian, Taylor, Anitha, Bernhard, Srinivasan, Greene (b0010) 2007; 207
Duda, Giasson, Chen, Gur, Hurtig, Stern, Gollomp, Ischiropoulos, Lee, Trojanowski (b0020) 2000; 157
Abe, Kimura (b0005) 1996; 16
Hu, Wong, Moore, Bian (b0035) 2007; 100
Warenycia, Smith, Blashko, Kombian, Reiffenstein (b0120) 1989; 63
Li, Whiteman, Guan, Neo, Cheng, Lee, Zhao, Baskar, Tan, Moore (b0070) 2008; 117
Enokido, Suzuki, Iwasawa, Namekata, Okazawa, Kimura (b0025) 2005; 19
Lu, Kavalier, Lukyanov, Gross (b0080) 2013; 62
Scheperjans, Aho, Pereira, Koskinen, Paulin, Pekkonen, Haapaniemi, Kaakkola, Eerola-Rautio, Pohja, Kinnunen, Murros, Auvinen (b0100) 2015; 30
Kleinknecht (10.1016/j.bbi.2017.07.159_b0060) 2016; 12
Duda (10.1016/j.bbi.2017.07.159_b0020) 2000; 157
Warenycia (10.1016/j.bbi.2017.07.159_b0120) 1989; 63
Hu (10.1016/j.bbi.2017.07.159_b0040) 2010; 9
Lu (10.1016/j.bbi.2017.07.159_b0085) 2012; 17
Vandiver (10.1016/j.bbi.2017.07.159_b0115) 2013; 4
Enokido (10.1016/j.bbi.2017.07.159_b0025) 2005; 19
Washio (10.1016/j.bbi.2017.07.159_b0125) 2005; 54
Schulz (10.1016/j.bbi.2017.07.159_b0105) 1995; 64
Yong (10.1016/j.bbi.2017.07.159_b0140) 2010; 88
Scheperjans (10.1016/j.bbi.2017.07.159_b0100) 2015; 30
Mustafa (10.1016/j.bbi.2017.07.159_b0095) 2009; 2
McGeer (10.1016/j.bbi.2017.07.159_b0090) 1988; 38
Yao (10.1016/j.bbi.2017.07.159_b0135) 2005; 92
Kida (10.1016/j.bbi.2017.07.159_b0050) 2011; 15
Liberatore (10.1016/j.bbi.2017.07.159_b0075) 1999; 5
Du (10.1016/j.bbi.2017.07.159_b0015) 2014; 451
Hu (10.1016/j.bbi.2017.07.159_b0035) 2007; 100
Li (10.1016/j.bbi.2017.07.159_b0065) 2017; 33
Kim (10.1016/j.bbi.2017.07.159_b0055) 2016; 39
Abe (10.1016/j.bbi.2017.07.159_b0005) 1996; 16
Li (10.1016/j.bbi.2017.07.159_b0070) 2008; 117
Anderson (10.1016/j.bbi.2017.07.159_b0010) 2007; 207
Gerhard (10.1016/j.bbi.2017.07.159_b0030) 2006; 21
Winslow (10.1016/j.bbi.2017.07.159_b0130) 2010; 190
Hu (10.1016/j.bbi.2017.07.159_b0045) 2011; 15
Lu (10.1016/j.bbi.2017.07.159_b0080) 2013; 62
Siow (10.1016/j.bbi.2017.07.159_b0110) 2013; 2013
References_xml – volume: 207
  start-page: 4
  year: 2007
  end-page: 12
  ident: b0010
  article-title: Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease
  publication-title: Exp. Neurol.
– volume: 19
  start-page: 1854
  year: 2005
  end-page: 1856
  ident: b0025
  article-title: Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS
  publication-title: FASEB J.
– volume: 38
  start-page: 1285
  year: 1988
  end-page: 1291
  ident: b0090
  article-title: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
  publication-title: Neurology
– volume: 64
  start-page: 936
  year: 1995
  end-page: 939
  ident: b0105
  article-title: Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice
  publication-title: J. Neurochem.
– volume: 2013
  start-page: 964034
  year: 2013
  ident: b0110
  article-title: In vivo evidence of increased nNOS activity in acute MPTP neurotoxicity: a functional pharmacological MRI study
  publication-title: BioMed Res. Int.
– volume: 33
  start-page: 62
  year: 2017
  end-page: 72
  ident: b0065
  article-title: A new perspective for Parkinson's disease: circadian rhythm
  publication-title: Neurosci. Bull.
– volume: 157
  start-page: 1439
  year: 2000
  end-page: 1445
  ident: b0020
  article-title: Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies
  publication-title: Am. J. Pathol.
– volume: 190
  start-page: 1023
  year: 2010
  end-page: 1037
  ident: b0130
  article-title: alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease
  publication-title: J. Cell. Biol.
– volume: 5
  start-page: 1403
  year: 1999
  end-page: 1409
  ident: b0075
  article-title: Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
  publication-title: Nat. Med.
– volume: 12
  start-page: e1006098
  year: 2016
  ident: b0060
  article-title: C-Terminal tyrosine residue modifications modulate the protective phosphorylation of serine 129 of alpha-synuclein in a yeast model of Parkinson's disease
  publication-title: PLoS Genet.
– volume: 4
  start-page: 1626
  year: 2013
  ident: b0115
  article-title: Sulfhydration mediates neuroprotective actions of parkin
  publication-title: Nat. Commun.
– volume: 54
  start-page: 889
  year: 2005
  end-page: 895
  ident: b0125
  article-title: Hydrogen sulfide-producing bacteria in tongue biofilm and their relationship with oral malodour
  publication-title: J. Med. Microbiol.
– volume: 100
  start-page: 1121
  year: 2007
  end-page: 1128
  ident: b0035
  article-title: Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia
  publication-title: J. Neurochem.
– volume: 92
  start-page: 948
  year: 2005
  end-page: 961
  ident: b0135
  article-title: Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes
  publication-title: J. Neurochem.
– volume: 15
  start-page: 343
  year: 2011
  end-page: 352
  ident: b0050
  article-title: Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease
  publication-title: Antioxid. Redox Signal.
– volume: 21
  start-page: 404
  year: 2006
  end-page: 412
  ident: b0030
  article-title: In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
  publication-title: Neurobiol. Dis.
– volume: 39
  start-page: 1160
  year: 2016
  end-page: 1170
  ident: b0055
  article-title: Neuroprotective effect of bee venom is mediated by reduced astrocyte activation in a subchronic MPTP-induced model of Parkinson's disease
  publication-title: Arch. Pharm. Res.
– volume: 30
  start-page: 350
  year: 2015
  end-page: 358
  ident: b0100
  article-title: Gut microbiota are related to Parkinson's disease and clinical phenotype
  publication-title: Movement Disord.
– volume: 451
  start-page: 239
  year: 2014
  end-page: 245
  ident: b0015
  article-title: Downregulation of cystathionine beta-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 17
  start-page: 849
  year: 2012
  end-page: 859
  ident: b0085
  article-title: The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels
  publication-title: Antioxid. Redox Signal.
– volume: 9
  start-page: 135
  year: 2010
  end-page: 146
  ident: b0040
  article-title: Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models
  publication-title: Aging Cell
– volume: 15
  start-page: 405
  year: 2011
  end-page: 419
  ident: b0045
  article-title: Hydrogen sulfide: neurophysiology and neuropathology
  publication-title: Antioxid. Redox Signal.
– volume: 62
  start-page: 177
  year: 2013
  end-page: 181
  ident: b0080
  article-title: S-sulfhydration/desulfhydration and S-nitrosylation/denitrosylation: a common paradigm for gasotransmitter signaling by H2S and NO
  publication-title: Methods
– volume: 117
  start-page: 2351
  year: 2008
  end-page: 2360
  ident: b0070
  article-title: Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide
  publication-title: Circulation
– volume: 88
  start-page: 482
  year: 2010
  end-page: 491
  ident: b0140
  article-title: Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl
  publication-title: Cardiovasc. Res.
– volume: 63
  start-page: 131
  year: 1989
  end-page: 136
  ident: b0120
  article-title: Monoamine oxidase inhibition as a sequel of hydrogen sulfide intoxication: increases in brain catecholamine and 5-hydroxytryptamine levels
  publication-title: Arch. Toxicol.
– volume: 16
  start-page: 1066
  year: 1996
  end-page: 1071
  ident: b0005
  article-title: The possible role of hydrogen sulfide as an endogenous neuromodulator
  publication-title: J. Neurosci.
– volume: 2
  start-page: ra72
  year: 2009
  ident: b0095
  article-title: H2S signals through protein S-sulfhydration
  publication-title: Sci. Signal.
– volume: 15
  start-page: 405
  year: 2011
  ident: 10.1016/j.bbi.2017.07.159_b0045
  article-title: Hydrogen sulfide: neurophysiology and neuropathology
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2010.3517
– volume: 54
  start-page: 889
  year: 2005
  ident: 10.1016/j.bbi.2017.07.159_b0125
  article-title: Hydrogen sulfide-producing bacteria in tongue biofilm and their relationship with oral malodour
  publication-title: J. Med. Microbiol.
  doi: 10.1099/jmm.0.46118-0
– volume: 12
  start-page: e1006098
  year: 2016
  ident: 10.1016/j.bbi.2017.07.159_b0060
  article-title: C-Terminal tyrosine residue modifications modulate the protective phosphorylation of serine 129 of alpha-synuclein in a yeast model of Parkinson's disease
  publication-title: PLoS Genet.
  doi: 10.1371/journal.pgen.1006098
– volume: 5
  start-page: 1403
  year: 1999
  ident: 10.1016/j.bbi.2017.07.159_b0075
  article-title: Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
  publication-title: Nat. Med.
  doi: 10.1038/70978
– volume: 64
  start-page: 936
  year: 1995
  ident: 10.1016/j.bbi.2017.07.159_b0105
  article-title: Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1995.64020936.x
– volume: 2
  start-page: ra72
  year: 2009
  ident: 10.1016/j.bbi.2017.07.159_b0095
  article-title: H2S signals through protein S-sulfhydration
  publication-title: Sci. Signal.
  doi: 10.1126/scisignal.2000464
– volume: 207
  start-page: 4
  year: 2007
  ident: 10.1016/j.bbi.2017.07.159_b0010
  article-title: Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease
  publication-title: Exp. Neurol.
  doi: 10.1016/j.expneurol.2007.05.010
– volume: 21
  start-page: 404
  year: 2006
  ident: 10.1016/j.bbi.2017.07.159_b0030
  article-title: In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2005.08.002
– volume: 62
  start-page: 177
  year: 2013
  ident: 10.1016/j.bbi.2017.07.159_b0080
  article-title: S-sulfhydration/desulfhydration and S-nitrosylation/denitrosylation: a common paradigm for gasotransmitter signaling by H2S and NO
  publication-title: Methods
  doi: 10.1016/j.ymeth.2013.05.020
– volume: 19
  start-page: 1854
  year: 2005
  ident: 10.1016/j.bbi.2017.07.159_b0025
  article-title: Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS
  publication-title: FASEB J.
  doi: 10.1096/fj.05-3724fje
– volume: 33
  start-page: 62
  year: 2017
  ident: 10.1016/j.bbi.2017.07.159_b0065
  article-title: A new perspective for Parkinson's disease: circadian rhythm
  publication-title: Neurosci. Bull.
  doi: 10.1007/s12264-016-0089-7
– volume: 17
  start-page: 849
  year: 2012
  ident: 10.1016/j.bbi.2017.07.159_b0085
  article-title: The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2011.4507
– volume: 4
  start-page: 1626
  year: 2013
  ident: 10.1016/j.bbi.2017.07.159_b0115
  article-title: Sulfhydration mediates neuroprotective actions of parkin
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms2623
– volume: 30
  start-page: 350
  year: 2015
  ident: 10.1016/j.bbi.2017.07.159_b0100
  article-title: Gut microbiota are related to Parkinson's disease and clinical phenotype
  publication-title: Movement Disord.
  doi: 10.1002/mds.26069
– volume: 92
  start-page: 948
  year: 2005
  ident: 10.1016/j.bbi.2017.07.159_b0135
  article-title: Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2004.02937.x
– volume: 88
  start-page: 482
  year: 2010
  ident: 10.1016/j.bbi.2017.07.159_b0140
  article-title: Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvq248
– volume: 39
  start-page: 1160
  year: 2016
  ident: 10.1016/j.bbi.2017.07.159_b0055
  article-title: Neuroprotective effect of bee venom is mediated by reduced astrocyte activation in a subchronic MPTP-induced model of Parkinson's disease
  publication-title: Arch. Pharm. Res.
  doi: 10.1007/s12272-016-0802-0
– volume: 451
  start-page: 239
  year: 2014
  ident: 10.1016/j.bbi.2017.07.159_b0015
  article-title: Downregulation of cystathionine beta-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2014.07.107
– volume: 190
  start-page: 1023
  year: 2010
  ident: 10.1016/j.bbi.2017.07.159_b0130
  article-title: alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease
  publication-title: J. Cell. Biol.
  doi: 10.1083/jcb.201003122
– volume: 2013
  start-page: 964034
  year: 2013
  ident: 10.1016/j.bbi.2017.07.159_b0110
  article-title: In vivo evidence of increased nNOS activity in acute MPTP neurotoxicity: a functional pharmacological MRI study
  publication-title: BioMed Res. Int.
  doi: 10.1155/2013/964034
– volume: 38
  start-page: 1285
  year: 1988
  ident: 10.1016/j.bbi.2017.07.159_b0090
  article-title: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
  publication-title: Neurology
  doi: 10.1212/WNL.38.8.1285
– volume: 63
  start-page: 131
  year: 1989
  ident: 10.1016/j.bbi.2017.07.159_b0120
  article-title: Monoamine oxidase inhibition as a sequel of hydrogen sulfide intoxication: increases in brain catecholamine and 5-hydroxytryptamine levels
  publication-title: Arch. Toxicol.
  doi: 10.1007/BF00316435
– volume: 100
  start-page: 1121
  year: 2007
  ident: 10.1016/j.bbi.2017.07.159_b0035
  article-title: Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2006.04283.x
– volume: 16
  start-page: 1066
  year: 1996
  ident: 10.1016/j.bbi.2017.07.159_b0005
  article-title: The possible role of hydrogen sulfide as an endogenous neuromodulator
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.16-03-01066.1996
– volume: 117
  start-page: 2351
  year: 2008
  ident: 10.1016/j.bbi.2017.07.159_b0070
  article-title: Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.107.753467
– volume: 157
  start-page: 1439
  year: 2000
  ident: 10.1016/j.bbi.2017.07.159_b0020
  article-title: Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies
  publication-title: Am. J. Pathol.
  doi: 10.1016/S0002-9440(10)64781-5
– volume: 9
  start-page: 135
  year: 2010
  ident: 10.1016/j.bbi.2017.07.159_b0040
  article-title: Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models
  publication-title: Aging Cell
  doi: 10.1111/j.1474-9726.2009.00543.x
– volume: 15
  start-page: 343
  year: 2011
  ident: 10.1016/j.bbi.2017.07.159_b0050
  article-title: Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2010.3671
SSID ssj0005318
Score 2.4299402
Snippet •Plasma and striatal sulfide levels were decreased in MPTP-induced PD mouse model.•CBS expression was reduced in the striatum and glial cells of MPTP-treated...
Hydrogen sulfide (H2S), a novel neuromodulator, is linked to the pathogenesis of several neurodegenerative disorders. Exogenous application of H2S exerts...
SourceID proquest
crossref
elsevier
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 77
SubjectTerms Cystathionine β-synthase
Hydrogen sulfide
Neuroinflammation
Nitrative stress
Parkinson’s disease
α-Synuclein nitration
Title Impaired CBS-H2S signaling axis contributes to MPTP-induced neurodegeneration in a mouse model of Parkinson’s disease
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0889159117303884
https://dx.doi.org/10.1016/j.bbi.2017.07.159
https://www.proquest.com/docview/1926681992
Volume 67
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS9xAEF9EofSlWG2pH5URig-F9C7J3m7yeD2U8-Pk6Cn4tuxudkuK5sQ7UV_Ef6P_Xv-SzmwSsUUs9Ckk7IZkZ3a-9jczjH1Ke12TFqmMcmlsxAvcinkhe1GWmdjbTBoReh2OjsXwlB-c9c4W2KDNhSFYZSP7a5kepHXzpNOsZueyLDsTAuigMo5jZNI0y6gmKOeSuPzL_ROYRx3jC2geGt2ebAaMlzElobsk1e-MqVzp87rpLykdVM_eMnvT2IzQrz_rLVtw1Qpb7VfoL1_cwQ4EFGcIj6-wV6PmsHyV3ezjVse_K2DwdRINkwkQWENT_jno23IGAaZO_a7cDOZTGI1PxhG66EjsAkKdy8J9D1WpiXhQVqCBAgUOQvscmHqgnOmQPvbr4ecMmsOed-x0b_dkMIyaPguRRWdwHhmeuCTl3OMOdDktZSK0lc4L4b3TQieFtzm3ec4NOoxSJ7FDu6CHrlbKbebS92yxmlbuAwGlHA4Q3jkfc69xaJGTjeQ12g3G-jXWbVdY2aYIOfXCOFct2uyHQqIoIorqSoVEWWOfH6dc1hU4XhqctGRTbWopCkOF-uGlSfxx0h-8969p2y1fKNyTdNCiK4dkUGg1C5ERsHf9_169wV7jXVaHejbZ4vzq2n1E42dutgJ3b7Gl_uDb0Ziu-4fD49-NfwVf
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGJwEvE2ygffBxSIgHpKhN4jjJY6mYUrZWk9pJe7Nsx0ZBI53WIuCNf4N_j7-EO8cZAqEh8dr4otTn-_Tv7hh7mWYjndZpHpW5NhGvURTLOs-iotCxM0WuhZ91OJuL6py_u8guttikr4UhWGXQ_Z1O99o6_DIMuzm8aprhggA6aIzjGA9pWhT8Dtum7lTZgG2PpyfV_BfSo0vzeUAPEfSXmx7mpXVDAK-cWnjG1LH07-bpD0Xtrc_xA7YT3EYYd1_2kG3ZdpftjVsMmT9-hVfggZw-Q77L7s7Cffke-zxFacc_WMPkzSKqkgUQXkNRCTqoL80aPFKdRl7ZNWxWMDtbnkUYpSO_a_CtLmv73jemJv5B04ICyhVY8BN0YOWAyqZ9BdmPb9_XEO57HrHz47fLSRWFUQuRwXhwE2me2CTl3KEQ2pJ2MxHK5NYJ4ZxVQiW1MyU3Zck1xoy5SmKLrkGG0VbKTWHTx2zQrlq7T1gpiwuEs9bF3ClcWpfkJjmFroM27oCN-h2WJvQhp3EYl7IHnH2QyBRJTJGjXCJTDtjrG5KrrgnHbYuTnm2yry5FfSjRRNxGxG-Ifjt-_yJ70Z8LiWJJdy2qtcgGiY6zEAVhew__79XP2b1qOTuVp9P5yRG7j0-KLvPzhA0215_sU_SFNvpZOOs_AUj2Bns
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impaired+CBS-H2S+signaling+axis+contributes+to+MPTP-induced+neurodegeneration+in+a+mouse+model+of+Parkinson%E2%80%99s+disease&rft.jtitle=Brain%2C+behavior%2C+and+immunity&rft.au=Yuan%2C+Yu-Qing&rft.au=Wang%2C+Ya-Li&rft.au=Yuan%2C+Bao-Shi&rft.au=Yuan%2C+Xin&rft.date=2018-01-01&rft.issn=0889-1591&rft.volume=67&rft.spage=77&rft.epage=90&rft_id=info:doi/10.1016%2Fj.bbi.2017.07.159&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_bbi_2017_07_159
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0889-1591&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0889-1591&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0889-1591&client=summon